Sexually transmitted diseases and HIV. A female perspective.
Sexually transmitted diseases have the greatest impact on the health of women. They are frequently asymptomatic, so screening for infection is important in preventing the long-term sequelae which include infertility, ectopic pregnancy, and chronic pelvic pain. HIV continues to increase in the female population and the gynecologic complications associated with it are unique to this population. Use of zidovudine in pregnant HIV-infected women has substantially decreased the rate of vertical transmission of HIV infection. The epidemiologic synergy between HIV and STDs is well recognized and prevention of one is dependent on prevention of the other.
Horgan
M
M
Division of Infectious Diseases, Cork University Hospital, Wilton, Ireland.
Bersoff-Matcha
S
S
D019380:Anti-HIV Agents / Q000627:therapeutic use; D015981:Epidemiologic Factors; D005260:Female; D015658:HIV Infections / Q000453:epidemiology / Q000517:prevention & control / Q000635:transmission*; D006801:Humans; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control; D007247:Infertility, Female / Q000209:etiology / Q000517:prevention & control; D008297:Male; D017699:Pelvic Pain / Q000209:etiology / Q000517:prevention & control; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000517:prevention & control; D011271:Pregnancy, Ectopic / Q000209:etiology / Q000517:prevention & control; D015229:Sexually Transmitted Diseases, Viral / Q000150:complications / Q000453:epidemiology / Q000517:prevention & control*; D002583:Uterine Cervical Neoplasms / Q000209:etiology / Q000517:prevention & control; D016387:Women's Health; D015215:Zidovudine / Q000627:therapeutic use
D019380:Anti-HIV Agents; D015215:Zidovudine